Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension

Viktor Persic1, Alen Ruzic, Bojan Miletic

  • 1Department of Cardiology, Thalassotherapia Opatija, M. Tita 188, 51410 Opatija, Croatia.

Insights

Newly diagnosed arterial hypertension significantly impairs left ventricular diastolic function in obese patients. This occurs before detectable structural changes, highlighting early intervention needs for cardiovascular health.

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Diagnostic Imaging

Background:

  • Obesity and arterial hypertension frequently coexist and are independent risk factors for diastolic dysfunction.
  • Limited data exists on diastolic dysfunction in obese patients with newly diagnosed hypertension.

Purpose of the Study:

  • To determine the prevalence of diastolic dysfunction in obese individuals with newly diagnosed arterial hypertension.
  • To compare diastolic function in this group with normotensive obese individuals.

Main Methods:

  • 125 obese patients were enrolled: 65 with new hypertension, 60 normotensive controls matched for age, sex, and BMI.
  • Doppler-echocardiography assessed left ventricular diastolic function using mitral inflow velocities, E/A ratio, and other parameters.
  • Diastolic dysfunction was defined by an E/A ratio <1.

Main Results:

  • Obese patients with new hypertension showed higher A wave, lower E/A ratio, longer E deceleration time, and larger left atria.
  • No significant differences were found in E wave peak velocities, left ventricle heart mass, or hypertrophy prevalence.
  • The prevalence of diastolic dysfunction was significantly higher in the newly hypertensive obese group.

Conclusions:

  • Newly diagnosed arterial hypertension contributes to impaired left ventricular diastolic function in obese patients.
  • This impairment occurs before structural echocardiographic changes become apparent.
  • Early detection and management of hypertension in obese individuals are crucial for preserving diastolic function.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...